Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
19.97
-2.55 (-11.32%)
At close: Apr 4, 2025, 4:00 PM
21.00
+1.03 (5.16%)
After-hours: Apr 4, 2025, 7:35 PM EDT

Apellis Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
781.37396.5975.4266.56250.65
Upgrade
Revenue Growth (YoY)
97.02%425.83%13.31%-73.44%-
Upgrade
Cost of Revenue
445.29412.9392.87426.0725.05
Upgrade
Gross Profit
336.07-16.31-317.45-359.51225.6
Upgrade
Selling, General & Admin
501.05500.82277.16176.77139.4
Upgrade
Research & Development
----299.92
Upgrade
Operating Expenses
501.05500.82277.16176.77439.32
Upgrade
Operating Income
-164.98-517.12-594.61-536.28-213.73
Upgrade
Interest Expense
-40.39-29.58-32.63-13.24-29.94
Upgrade
Interest & Investment Income
12.7720.938.910.424.16
Upgrade
Other Non Operating Income (Expenses)
-2.17-0.73-0.29-96.31-103.53
Upgrade
EBT Excluding Unusual Items
-194.77-526.5-618.61-645.41-343.03
Upgrade
Other Unusual Items
-1.95--32.89-100.59-
Upgrade
Pretax Income
-196.72-526.5-651.5-746-343.03
Upgrade
Income Tax Expense
1.162.130.670.351.85
Upgrade
Net Income
-197.88-528.63-652.17-746.35-344.87
Upgrade
Net Income to Common
-197.88-528.63-652.17-746.35-344.87
Upgrade
Shares Outstanding (Basic)
1241191068475
Upgrade
Shares Outstanding (Diluted)
1241191068475
Upgrade
Shares Change (YoY)
4.40%11.84%25.70%12.32%20.79%
Upgrade
EPS (Basic)
-1.60-4.45-6.15-8.84-4.59
Upgrade
EPS (Diluted)
-1.60-4.45-6.15-8.84-4.59
Upgrade
Free Cash Flow
-88.27-595.51-515.27-564.23-165.91
Upgrade
Free Cash Flow Per Share
-0.71-5.02-4.86-6.68-2.21
Upgrade
Gross Margin
43.01%-4.11%--90.01%
Upgrade
Operating Margin
-21.11%-130.39%-788.38%-805.67%-85.27%
Upgrade
Profit Margin
-25.32%-133.29%-864.70%-1121.28%-137.59%
Upgrade
Free Cash Flow Margin
-11.30%-150.16%-683.18%-847.66%-66.19%
Upgrade
EBITDA
-163.18-515.34-593.06-534.9-213.09
Upgrade
EBITDA Margin
-20.88%-129.94%---85.02%
Upgrade
D&A For EBITDA
1.81.781.551.380.64
Upgrade
EBIT
-164.98-517.12-594.61-536.28-213.73
Upgrade
EBIT Margin
-21.11%-130.39%---85.27%
Upgrade
Revenue as Reported
781.37396.5975.4266.56250.65
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q